# Inhaled Budesonide for Non-ventilated Infants at High Risk of Bronchopulmonary Dysplasia: the i-BUD Pilot Study

> **NCT01895075** · PHASE2 · WITHDRAWN · sponsor: **Dr. Michael Dunn**

## Conditions studied

- Bronchopulmonary Dysplasia

## Interventions

- **DRUG:** Inhaled budesonide
- **DRUG:** Normal saline

## Key facts

- **NCT ID:** NCT01895075
- **Lead sponsor:** Dr. Michael Dunn
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-01-01
- **Primary completion:** 2020-07-01
- **Final completion:** 2020-09-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Insufficient funding
- **Last updated:** 2018-08-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01895075

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01895075, "Inhaled Budesonide for Non-ventilated Infants at High Risk of Bronchopulmonary Dysplasia: the i-BUD Pilot Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01895075. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*